Your browser doesn't support javascript.
loading
Tissue-specific genetic variation suggests distinct molecular pathways between body shape phenotypes and colorectal cancer.
Peruchet-Noray, Laia; Sedlmeier, Anja M; Dimou, Niki; Baurecht, Hansjörg; Fervers, Béatrice; Fontvieille, Emma; Konzok, Julian; Tsilidis, Kostas K; Christakoudi, Sofia; Jansana, Anna; Cordova, Reynalda; Bohmann, Patricia; Stein, Michael J; Weber, Andrea; Bézieau, Stéphane; Brenner, Hermann; Chan, Andrew T; Cheng, Iona; Figueiredo, Jane C; Garcia-Etxebarria, Koldo; Moreno, Victor; Newton, Christina C; Schmit, Stephanie L; Song, Mingyang; Ulrich, Cornelia M; Ferrari, Pietro; Viallon, Vivian; Carreras-Torres, Robert; Gunter, Marc J; Freisling, Heinz.
Affiliation
  • Peruchet-Noray L; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
  • Sedlmeier AM; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Dimou N; Center for Translational Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Baurecht H; Bavarian Cancer Research Center (BZKF), Regensburg, Germany.
  • Fervers B; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Fontvieille E; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
  • Konzok J; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Tsilidis KK; Département Prévention Cancer Environnement, Centre Léon Bérard, Lyon, France.
  • Christakoudi S; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
  • Jansana A; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Cordova R; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
  • Bohmann P; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Stein MJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
  • Weber A; Department of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Bézieau S; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
  • Brenner H; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
  • Chan AT; Department of Nutritional Sciences, University of Vienna, Vienna, Austria.
  • Cheng I; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Figueiredo JC; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Garcia-Etxebarria K; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Moreno V; Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France.
  • Newton CC; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schmit SL; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Song M; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ulrich CM; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Ferrari P; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Viallon V; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Carreras-Torres R; Biodonostia, Gastrointestinal Genetics Group, San Sebastián, Spain.
  • Gunter MJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
  • Freisling H; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
Sci Adv ; 10(16): eadj1987, 2024 Apr 19.
Article in En | MEDLINE | ID: mdl-38640244
ABSTRACT
It remains unknown whether adiposity subtypes are differentially associated with colorectal cancer (CRC). To move beyond single-trait anthropometric indicators, we derived four multi-trait body shape phenotypes reflecting adiposity subtypes from principal components analysis on body mass index, height, weight, waist-to-hip ratio, and waist and hip circumference. A generally obese (PC1) and a tall, centrally obese (PC3) body shape were both positively associated with CRC risk in observational analyses in 329,828 UK Biobank participants (3728 cases). In genome-wide association studies in 460,198 UK Biobank participants, we identified 3414 genetic variants across four body shapes and Mendelian randomization analyses confirmed positive associations of PC1 and PC3 with CRC risk (52,775 cases/45,940 controls from GECCO/CORECT/CCFR). Brain tissue-specific genetic instruments, mapped to PC1 through enrichment analysis, were responsible for the relationship between PC1 and CRC, while the relationship between PC3 and CRC was predominantly driven by adipose tissue-specific genetic instruments. This study suggests distinct putative causal pathways between adiposity subtypes and CRC.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Somatotypes / Colorectal Neoplasms Limits: Humans Language: En Journal: Sci Adv Year: 2024 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Somatotypes / Colorectal Neoplasms Limits: Humans Language: En Journal: Sci Adv Year: 2024 Type: Article Affiliation country: France